Bo Zheng
About Bo Zheng
Bo Zheng is a Senior Director at Asklepios BioPharmaceutical, Inc., with a Master's Degree in Biomedical Engineering from the University of North Carolina at Chapel Hill. He has extensive experience in clinical development and data management, having previously worked at GSK and Regeneron Pharmaceuticals.
Work at Asklepios BioPharmaceutical
Bo Zheng has been serving as Senior Director at Asklepios BioPharmaceutical, Inc. (AskBio) since 2022. Located in Research Triangle Park (RTP), North Carolina, Zheng plays a crucial role in overseeing clinical development and operations. His extensive background in clinical trials and data management supports AskBio's mission to advance gene therapies and innovative treatments. Zheng's leadership is informed by his previous experiences in both global and China-based clinical environments.
Education and Expertise
Bo Zheng holds a Master's Degree in Biomedical Engineering from the University of North Carolina at Chapel Hill. Additionally, he studied at the Medical Center of Beijing University. His academic background provides a strong foundation in biomedical research and clinical development. Zheng possesses specialized knowledge in pharmacogenetics and is proficient in Clinical Data Interchange Standards Consortium (CDISC) standards, which are essential for clinical data management.
Background in Clinical Development
Zheng has a robust background in clinical development, having worked at GSK for 12 years in various roles, including Clinical Development Scientist and Manager of Clinical Data Science. His tenure at GSK involved implementing electronic data capture (EDC) systems and Risk-Based Monitoring strategies for clinical trials in China. Zheng also contributed to the development of a study model that enabled the China team to conduct global trials, showcasing his expertise in bridging local and international clinical practices.
Previous Experience at Regeneron Pharmaceuticals
Before joining AskBio, Bo Zheng worked at Regeneron Pharmaceuticals, Inc. as Head of Data Management Operations from 2019 to 2022. In this role, he managed data operations for clinical trials, ensuring compliance with industry standards and enhancing data integrity. His leadership in data management operations contributed to the successful execution of clinical studies, further solidifying his expertise in the pharmaceutical industry.
Involvement in Biomedical Research
Bo Zheng has been actively involved in biomedical research throughout his career, contributing to various publications in the field. His research experience complements his extensive work in clinical trials, allowing him to apply scientific insights to practical applications in drug development. Zheng's hands-on experience with clinical trials conducted globally and in China enhances his ability to navigate complex research environments.